VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria.
about
Acquired immunity to malariaThe Structure of a Chondroitin Sulfate-binding Domain Important in Placental MalariaStructure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate AStructural Comparison of Two CSPG-Binding DBL Domains from the VAR2CSA Protein Important in Malaria during PregnancyPlacental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic reviewPeripheral blood cell signatures of Plasmodium falciparum infection during pregnancyA method for visualizing surface-exposed and internal PfEMP1 adhesion antigens in Plasmodium falciparum infected erythrocytes.Recrudescent Plasmodium berghei from pregnant mice displays enhanced binding to the placenta and induces protection in multigravidaMultiple var2csa-type PfEMP1 genes located at different chromosomal loci occur in many Plasmodium falciparum isolatesHistopathologies, immunolocalization, and a glycan binding screen provide insights into Plasmodium falciparum interactions with the human placenta.Human monoclonal IgG selection of Plasmodium falciparum for the expression of placental malaria-specific variant surface antigensIdentification and characterization of B-cell epitopes in the DBL4ε domain of VAR2CSAHow specific is Plasmodium falciparum adherence to chondroitin 4-sulfate?Parity-dependent recognition of DBL1X-3X suggests an important role of the VAR2CSA high-affinity CSA-binding region in the development of the humoral response against placental malaria.Malaria and immunity during pregnancy and postpartum: a tale of two speciesParasitologic Assessment of Two-Dose and Monthly Intermittent Preventive Treatment of Malaria during Pregnancy with Sulphadoxine-Pyrimethamine (IPTP-SP) in Lagos, NigeriaProspects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites.Molecular dissection of placental malaria protein VAR2CSA interaction with a chemo-enzymatically synthesized chondroitin sulfate library.Prevalence of Plasmodium falciparum Malaria among Pregnant Students in Dodoma Region, Tanzania: No Cases Have Been DetectedChondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.Plasmodium falciparum: Assessment of parasite-infected red blood cell binding to placental chondroitin proteoglycan and bovine tracheal chondroitin sulfate A.Assessing the burden of pregnancy-associated malaria under changing transmission settings.A molecular switch in the efficiency of translation reinitiation controls expression of var2csa, a gene implicated in pregnancy-associated malaria.Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade.Virus-Like-Vaccines against HIV.An upstream open reading frame (uORF) signals for cellular localization of the virulence factor implicated in pregnancy associated malaria.IgG Responses to the Plasmodium falciparum Antigen VAR2CSA in Colombia Are Restricted to Pregnancy and Are Not Induced by Exposure to Plasmodium vivax
P2860
Q24651173-934556C4-E3F3-4271-9EF0-D34C69C51DD8Q27650818-15420FAB-FEE6-48B2-92C3-DF5927A546D0Q27653526-8B5D4FC5-2696-4DD2-B942-7F2E3786AA55Q27657099-B4C847A9-1ED1-4845-ABE0-79C942EA0898Q27973758-D175EC66-F1DD-4197-84BB-3A4CD1F8BEB3Q28079877-C51BD648-9E40-4BD9-8B25-45701F71D420Q31108883-19F923A3-5C03-4621-8E77-817CE5B08DFFQ33340826-F8742EEC-2D28-4C93-89ED-6D6078D7A355Q33450639-B5B84AF3-1FAF-407C-A8A5-671C2989923FQ33494832-48391CB4-1B61-4DF6-AD6D-1CB20445DAC7Q33806360-3F7934F7-8CA4-42BF-8E5A-4F5B025B401BQ34401253-2BA2DB79-CF62-4BF4-A613-319CBF3F783AQ34412101-C69FDAF3-FD8F-4D06-910E-203DBAD49070Q35156896-955FF865-1E62-4FA3-B046-FA84AC8F2A68Q35609294-8B2870B9-9908-4550-AC44-91C8B77C812BQ35678578-7160AC75-FD7C-4748-B797-14882A02EAE0Q35692279-F332677B-590B-4841-B649-90844B1283C7Q35738477-49E21BE5-20BC-4CD8-A343-7761728B240CQ36048885-20E55464-F853-4848-9C24-D6E00EA6A670Q36343129-C4D4CE9A-B945-4BE8-8B6A-AE34010A9D77Q36672347-2688BE24-0409-48CA-AFF1-4607A2516695Q37354879-FFE9DD85-2004-4E93-A660-8502E133DC10Q37414302-51FF3A4F-2737-4692-AE9C-B239400FA452Q37610154-B5623606-3923-4BAC-8E4B-00AAD39EEBDAQ39341627-9B58E5E9-7169-4141-B4B8-1BE7A6EE436CQ50034030-D1F938C6-0BC5-4D5B-9EA2-50E5CA9C9C2FQ52648637-5A09A7B5-6A38-4B0E-A738-26441EE939B2Q56358725-68E1E0CD-1793-4738-A275-1A72CBB9BF60
P2860
VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
VAR2CSA and protective immunit ...... Plasmodium falciparum malaria.
@ast
VAR2CSA and protective immunit ...... Plasmodium falciparum malaria.
@en
VAR2CSA and protective immunit ...... Plasmodium falciparum malaria.
@nl
type
label
VAR2CSA and protective immunit ...... Plasmodium falciparum malaria.
@ast
VAR2CSA and protective immunit ...... Plasmodium falciparum malaria.
@en
VAR2CSA and protective immunit ...... Plasmodium falciparum malaria.
@nl
prefLabel
VAR2CSA and protective immunit ...... Plasmodium falciparum malaria.
@ast
VAR2CSA and protective immunit ...... Plasmodium falciparum malaria.
@en
VAR2CSA and protective immunit ...... Plasmodium falciparum malaria.
@nl
P2860
P921
P1433
P1476
VAR2CSA and protective immunit ...... Plasmodium falciparum malaria
@en
P2093
P2860
P304
P356
10.1017/S0031182007000121
P577
2007-01-01T00:00:00Z